Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Sporadic deficient mismatch repair in colorectal cancer increases the risk for non-colorectal malignancy: A European multicenter cohort study

I. Gkekas, N. Jan, T. Kaprio, I. Beilmann-Lehtonen, P. Fabian, B. Tavelin, C. Böckelman, S. Edin, K. Strigård, T. Svoboda, J. Hagström, L. Barsova, T. Jirasek, C. Haglund, R. Palmqvist, U. Gunnarsson

. 2024 ; 129 (7) : 1295-1304. [pub] 20240312

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, multicentrická studie

Perzistentní odkaz   https://www.medvik.cz/link/bmc24013755

Grantová podpora
Cancer Research Foundation in Northern Sweden
Visare Norr

BACKGROUND AND OBJECTIVES: Disparities between tumors arising via different sporadic carcinogenetic pathways have not been studied systematically. This retrospective multicenter cohort study evaluated the differences in the risk for non-colorectal malignancy between sporadic colorectal cancer (CRC) patients from different DNA mismatch repair status. METHODS: A retrospective European multicenter cohort study including in total of 1706 CRC patients treated between 1996 and 2019 in three different countries. The proficiency (pMMR) or deficiency (dMMR) of mismatch repair was determined by immunohistochemistry. Cases were analyzed for tumor BRAFV600E mutation, and BRAF mutated tumors were further analyzed for hypermethylation status in the promoter region of MLH1 to distinguish between sporadic and hereditary cases. Swedish and Finish patients were matched with their respective National Cancer Registries. For the Czech cohort, thorough scrutiny of medical files was performed to identify any non-colorectal malignancy within 20 years before or after the diagnosis of CRC. Poisson regression analysis was performed to identify the incidence rates of non-colorectal malignancies. For validation purposes, standardized incidence ratios were calculated for the Swedish cases adjusted for age, year, and sex. RESULTS: Of the 1706 CRC patients included in the analysis, 819 were female [48%], median age at surgery was 67 years [interquartile range: 60-75], and sporadic dMMR was found in 188 patients (11%). Patients with sporadic dMMR CRC had a higher incidence rate ratio (IRR) for non-colorectal malignancy before and after diagnosis compared to patients with a pMMR tumor, in both uni- (IRR = 2.49, 95% confidence interval [CI] = 1.89-3.31, p = 0.003) and multivariable analysis (IRR = 2.24, 95% CI = 1.67-3.01, p = 0.004). This association applied whether or not the non-colorectal tumor developed before or after the diagnosis of CRC in both uni- (IRR = 1.91, 95% CI = 1.28-2.98, p = 0.004), (IRR = 2.45, 95% CI = 1.72-3.49, p = 0.004) and multivariable analysis (IRR = 1.67,95% CI = 1.05-2.65, p = 0.029), (IRR = 2.35, 95% CI = 1.63-3.42, p = 0.005), respectively. CONCLUSION: In this retrospective European multicenter cohort study, patients with sporadic dMMR CRC had a higher risk for non-colorectal malignancy than those with pMMR CRC. These findings indicate the need for further studies to establish the need for and design of surveillance strategies for patients with dMMR CRC.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24013755
003      
CZ-PrNML
005      
20240905134033.0
007      
ta
008      
240725s2024 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1002/jso.27619 $2 doi
035    __
$a (PubMed)38470492
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Gkekas, Ioannis $u Department of Surgical and Perioperative Sciences, Surgery, Umeå University, Umeå, Sweden
245    10
$a Sporadic deficient mismatch repair in colorectal cancer increases the risk for non-colorectal malignancy: A European multicenter cohort study / $c I. Gkekas, N. Jan, T. Kaprio, I. Beilmann-Lehtonen, P. Fabian, B. Tavelin, C. Böckelman, S. Edin, K. Strigård, T. Svoboda, J. Hagström, L. Barsova, T. Jirasek, C. Haglund, R. Palmqvist, U. Gunnarsson
520    9_
$a BACKGROUND AND OBJECTIVES: Disparities between tumors arising via different sporadic carcinogenetic pathways have not been studied systematically. This retrospective multicenter cohort study evaluated the differences in the risk for non-colorectal malignancy between sporadic colorectal cancer (CRC) patients from different DNA mismatch repair status. METHODS: A retrospective European multicenter cohort study including in total of 1706 CRC patients treated between 1996 and 2019 in three different countries. The proficiency (pMMR) or deficiency (dMMR) of mismatch repair was determined by immunohistochemistry. Cases were analyzed for tumor BRAFV600E mutation, and BRAF mutated tumors were further analyzed for hypermethylation status in the promoter region of MLH1 to distinguish between sporadic and hereditary cases. Swedish and Finish patients were matched with their respective National Cancer Registries. For the Czech cohort, thorough scrutiny of medical files was performed to identify any non-colorectal malignancy within 20 years before or after the diagnosis of CRC. Poisson regression analysis was performed to identify the incidence rates of non-colorectal malignancies. For validation purposes, standardized incidence ratios were calculated for the Swedish cases adjusted for age, year, and sex. RESULTS: Of the 1706 CRC patients included in the analysis, 819 were female [48%], median age at surgery was 67 years [interquartile range: 60-75], and sporadic dMMR was found in 188 patients (11%). Patients with sporadic dMMR CRC had a higher incidence rate ratio (IRR) for non-colorectal malignancy before and after diagnosis compared to patients with a pMMR tumor, in both uni- (IRR = 2.49, 95% confidence interval [CI] = 1.89-3.31, p = 0.003) and multivariable analysis (IRR = 2.24, 95% CI = 1.67-3.01, p = 0.004). This association applied whether or not the non-colorectal tumor developed before or after the diagnosis of CRC in both uni- (IRR = 1.91, 95% CI = 1.28-2.98, p = 0.004), (IRR = 2.45, 95% CI = 1.72-3.49, p = 0.004) and multivariable analysis (IRR = 1.67,95% CI = 1.05-2.65, p = 0.029), (IRR = 2.35, 95% CI = 1.63-3.42, p = 0.005), respectively. CONCLUSION: In this retrospective European multicenter cohort study, patients with sporadic dMMR CRC had a higher risk for non-colorectal malignancy than those with pMMR CRC. These findings indicate the need for further studies to establish the need for and design of surveillance strategies for patients with dMMR CRC.
650    _2
$a lidé $7 D006801
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a mužské pohlaví $7 D008297
650    12
$a kolorektální nádory $x genetika $x patologie $x epidemiologie $x etiologie $7 D015179
650    _2
$a retrospektivní studie $7 D012189
650    _2
$a senioři $7 D000368
650    _2
$a lidé středního věku $7 D008875
650    12
$a oprava chybného párování bází DNA $7 D053843
650    _2
$a protoonkogenní proteiny B-Raf $x genetika $7 D048493
650    _2
$a následné studie $7 D005500
650    _2
$a MutL homolog 1 $x genetika $7 D000070957
650    _2
$a mutace $7 D009154
650    _2
$a prognóza $7 D011379
650    _2
$a incidence $7 D015994
651    _2
$a Evropa $x epidemiologie $7 D005060
651    _2
$a Švédsko $x epidemiologie $7 D013548
655    _2
$a časopisecké články $7 D016428
655    _2
$a multicentrická studie $7 D016448
700    1_
$a Jan, Novotny $u Department of Surgical and Perioperative Sciences, Surgery, Umeå University, Umeå, Sweden
700    1_
$a Kaprio, Tuomas $u Department of Gastrointestinal Surgery, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
700    1_
$a Beilmann-Lehtonen, Ines $u Department of Transplantation and Liver Surgery, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
700    1_
$a Fabian, Pavel $u Department of Oncological Pathology, Masaryk Memorial Cancer Institute, Brno, Czech Republic
700    1_
$a Tavelin, Björn $u Department of Radiation Sciences, Umeå University, Umeå, Sweden
700    1_
$a Böckelman, Camilla $u Department of Gastrointestinal Surgery, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
700    1_
$a Edin, Sofia $u Department of Medical Biosciences, Pathology, Umeå University, Umeå, Sweden
700    1_
$a Strigård, Karin $u Department of Surgical and Perioperative Sciences, Surgery, Umeå University, Umeå, Sweden
700    1_
$a Svoboda, Tomas $u Department of Oncology and Radiotherapy, Faculty Hospital Pilsen, Charles University, Prague, Czech Republic
700    1_
$a Hagström, Jaana $u Department of Pathology, University of Helsinki, Helsinki, Finland $u Department of Oral Pathology and Radiology, University of Turku, Turku, Finland
700    1_
$a Barsova, Lucie $u Department of Clinical Oncology, Comprehensive Oncology Center, Liberec, Czech Republic
700    1_
$a Jirasek, Tomas $u Department of Pathology, Regional Hospital of Liberec, Liberec, Czech Republic
700    1_
$a Haglund, Caj $u Department of Gastrointestinal Surgery, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
700    1_
$a Palmqvist, Richard $u Department of Medical Biosciences, Pathology, Umeå University, Umeå, Sweden
700    1_
$a Gunnarsson, Ulf $u Department of Surgical and Perioperative Sciences, Surgery, Umeå University, Umeå, Sweden
773    0_
$w MED00010662 $t Journal of surgical oncology $x 1096-9098 $g Roč. 129, č. 7 (2024), s. 1295-1304
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38470492 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240725 $b ABA008
991    __
$a 20240905134026 $b ABA008
999    __
$a ok $b bmc $g 2143516 $s 1225621
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 129 $c 7 $d 1295-1304 $e 20240312 $i 1096-9098 $m Journal of surgical oncology $n J Surg Oncol $x MED00010662
GRA    __
$p Cancer Research Foundation in Northern Sweden
GRA    __
$p Visare Norr
LZP    __
$a Pubmed-20240725

Najít záznam

Citační ukazatele

Možnosti archivace